Arteritic Ischemic Optic Neuropathy

Ischemic optic neuropathy is an important cause of blindness. There are two types of ischemic optic neuropathy: posterior and anterior ischemic optic neuropathy (AION). The arteritic type of AION (AAION) is usually due to giant cell arteritis. Giant cell arteritis can present with visual loss alone in up to 25% of cases. AAION is considered a neuro-ophthalmologic emergency. Early recognition and treatment of AAION is crucial to prevent severe visual loss. The gold standard of treatment is corticosteroids. There is no consensus in the literature on the optimal treatment approach in steroid-resistant or steroid-contraindicated cases. Biologic agents, especially tocilizumab, show promise in resistant cases.

Authors

Publication Details

Journal
Güncel Retina Dergisi (Current Retina Journal)
Published
2024-09-13
DOI
https://doi.org/10.37783/crj-0431
Primary Topic
Intraoperative Neuromonitoring and Anesthetic Effects
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Arteritic Ischemic Optic Neuropathy

Ayşe Bozkurt Oflaz, Şule Acar Duyan, Emine Tınkır Kayıtmazbatır
Güncel Retina Dergisi (Current Retina Journal)
Intraoperative Neuromonitoring and Anesthetic Effects
article

Arteritic Ischemic Optic Neuropathy

Ayşe Bozkurt Oflaz, Şule Acar Duyan, Emine Tınkır Kayıtmazbatır
article en

Abstract

Ischemic optic neuropathy is an important cause of blindness. There are two types of ischemic optic neuropathy: posterior and anterior ischemic optic neuropathy (AION). The arteritic type of AION (AAION) is usually due to giant cell arteritis. Giant cell arteritis can present with visual loss alone in up to 25% of cases. AAION is considered a neuro-ophthalmologic emergency. Early recognition and treatment of AAION is crucial to prevent severe visual loss. The gold standard of treatment is corticosteroids. There is no consensus in the literature on the optimal treatment approach in steroid-resistant or steroid-contraindicated cases. Biologic agents, especially tocilizumab, show promise in resistant cases.

Güncel Retina Dergisi (Current Retina Journal)Vol. 9(1)
Openalex Percentile: Top 68%
Intraoperative Neuromonitoring and Anesthetic Effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.